First AD

Second AD

Stone is professor of medicine at Harvard Medical School and the Edward A Fox Chair in Medicine at the Massachusetts General Hospital. He has treated IgG4-related disease (IgG4-RD) since its emergence in recent years and is passionate about educating patients and fellow healthcare providers (HCPs) about the indolent and systemic nature of this disease.

Clinical Experience with Tocilizumab and Upadacitinib in GCA Treatment

This video covers the following questions:

Please share your clinical experience with tocilizumab and upadacitinib.

Let’s discuss treatment selection criteria for approved therapies. What patient subgroups would you consider for targeted agents, and what factors would contribute towards selecting one treatment over another?

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Video Series

Navigating Giant Cell Arteritis: Diagnosis, Management, and the Road Ahead

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Clinical Experience with Tocilizumab and Upadacitinib in GCA Treatment 